These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Hormone secretion by dispersed cell cultures of human pituitary adenomas: effects of theophylline, thyrotropin-releasing hormone, somatostatin, and 2-bromo-alpha-ergocryptine. Adams EF; Brajkovich IE; Mashiter K J Clin Endocrinol Metab; 1979 Jul; 49(1):120-6. PubMed ID: 109461 [No Abstract] [Full Text] [Related]
6. [Endocrinological evaluation of sellar and suprasellar tumor cases (the 2nd report);--on postoperative pituitary function (author's transl)]. Uozumi T; Mori S; Watanabe M; Takimoto N; Mogami H No Shinkei Geka; 1976 Jan; 4(1):73-8. PubMed ID: 176607 [TBL] [Abstract][Full Text] [Related]
8. Management of hormone-secreting pituitary microadenomas. Gáspár L; Kocsis J; Kemény A; Pásztor E; László FA Acta Med Hung; 1983; 40(2-3):107-24. PubMed ID: 6322100 [TBL] [Abstract][Full Text] [Related]
9. The role of somatostatin in the regulation of anterior pituitary hormone secretion and the use of its analogs in the treatment of human pituitary tumors. Lamberts SW Endocr Rev; 1988 Nov; 9(4):417-36. PubMed ID: 2905987 [No Abstract] [Full Text] [Related]
10. [Immunohistochemical and ultrastructural study of plurihormonal pituitary adenomas]. Liu DG Zhonghua Yi Xue Za Zhi; 1993 Apr; 73(4):223-5, 254. PubMed ID: 8395317 [TBL] [Abstract][Full Text] [Related]
11. [The impact of surgical treatment on endocrinological status of pituitary adenomas associated with hyperprolactinemia (author's transl)]. Sato O; Hotta H; Nakagawa T; Sohma F; Hasunuma M; Tsuchida H; Tanabe S; Kobayashi K; Inoue Y No Shinkei Geka; 1982 Jan; 10(1):55-62. PubMed ID: 6281676 [No Abstract] [Full Text] [Related]
12. [Endocrinological evaluation of sellar and suprasellar tumor cases (author's transl)]. Mori S; Uozumi T; Watanabe M; Takimoto N; Mogami H No Shinkei Geka; 1976 Mar; 4(3):235-42. PubMed ID: 179027 [TBL] [Abstract][Full Text] [Related]
13. Pituitary pathology associated with abnormalities of prolactin secretion. McCarty KS; Dobson CE Clin Obstet Gynecol; 1980 Jun; 23(2):267-84. PubMed ID: 6249531 [No Abstract] [Full Text] [Related]
14. Endocrine, biochemical, and morphological studies of a pituitary adenoma secreting growth hormone, thyrotropin (TSH), and alpha-subunit: evidence for secretion of TSH with increased bioactivity. Beck-Peccoz P; Piscitelli G; Amr S; Ballabio M; Bassetti M; Giannattasio G; Spada A; Nissim M; Weintraub BD; Faglia G J Clin Endocrinol Metab; 1986 Apr; 62(4):704-11. PubMed ID: 2419356 [TBL] [Abstract][Full Text] [Related]
15. Current concepts in cancer: management of hormone-secreting pituitary adenomas. Zervas NT; Martin JB N Engl J Med; 1980 Jan; 302(4):210-4. PubMed ID: 6985705 [No Abstract] [Full Text] [Related]
16. Management of pituitary adenomas. Leavens ME; McCutcheon IF; Samaan NA Oncology (Williston Park); 1992 Jun; 6(6):69-79; discussion 79-80. PubMed ID: 1319190 [TBL] [Abstract][Full Text] [Related]
18. [Classification of pituitary adenomas in terms of immunohistochemistry and ultrastructure]. Hori T No Shinkei Geka; 1986 Mar; 14(4):479-90. PubMed ID: 3012389 [No Abstract] [Full Text] [Related]
19. Effect of thyrotropin-releasing hormone and bromoergocriptine on growth hormone and prolactin secretion in perfused pituitary adenoma tissues of acromegaly. Ishibashi M; Yamaji T J Clin Endocrinol Metab; 1978 Dec; 47(6):1251-6. PubMed ID: 122426 [TBL] [Abstract][Full Text] [Related]